Literature DB >> 24509156

Ceruloplasmin and β-amyloid precursor protein confer neuroprotection in traumatic brain injury and lower neuronal iron.

Scott Ayton1, Moses Zhang2, Blaine R Roberts1, Linh Q Lam1, Monica Lind1, Catriona McLean3, Ashley I Bush4, Tony Frugier5, Peter J Crack2, James A Duce6.   

Abstract

Traumatic brain injury (TBI) is in part complicated by pro-oxidant iron elevation independent of brain hemorrhage. Ceruloplasmin (CP) and β-amyloid protein precursor (APP) are known neuroprotective proteins that reduce oxidative damage through iron regulation. We surveyed iron, CP, and APP in brain tissue from control and TBI-affected patients who were stratified according to time of death following injury. We observed CP and APP induction after TBI accompanying iron accumulation. Elevated APP and CP expression was also observed in a mouse model of focal cortical contusion injury concomitant with iron elevation. To determine if changes in APP or CP were neuroprotective we employed the same TBI model on APP(-/-) and CP(-/-) mice and found that both exhibited exaggerated infarct volume and iron accumulation postinjury. Evidence supports a regulatory role of both proteins in defence against iron-induced oxidative damage after TBI, which presents as a tractable therapeutic target.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid precursor protein; Ceruloplasmin; Free radicals; Iron; Mouse models; Traumatic brain injury

Mesh:

Substances:

Year:  2014        PMID: 24509156     DOI: 10.1016/j.freeradbiomed.2014.01.041

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  25 in total

Review 1.  Making sense of gut feelings in the traumatic brain injury pathogenesis.

Authors:  Luiz Fernando Freire Royes; Fernando Gomez-Pinilla
Journal:  Neurosci Biobehav Rev       Date:  2019-05-16       Impact factor: 8.989

Review 2.  Amyloid precursor protein-mediated mitochondrial regulation and Alzheimer's disease.

Authors:  M Isabel G Lopez Sanchez; Peter van Wijngaarden; Ian A Trounce
Journal:  Br J Pharmacol       Date:  2018-12-18       Impact factor: 8.739

Review 3.  Treating Alzheimer's disease by targeting iron.

Authors:  Sara Nikseresht; Ashley I Bush; Scott Ayton
Journal:  Br J Pharmacol       Date:  2019-02-11       Impact factor: 8.739

Review 4.  The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.

Authors:  Laura Mahoney-Sanchez; Abdel Ali Belaidi; Ashley I Bush; Scott Ayton
Journal:  J Mol Neurosci       Date:  2016-09-19       Impact factor: 3.444

5.  Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice.

Authors:  Abdel A Belaidi; Adam P Gunn; Bruce X Wong; Scott Ayton; Ambili T Appukuttan; Blaine R Roberts; James A Duce; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 6.  Biometals and their therapeutic implications in Alzheimer's disease.

Authors:  Scott Ayton; Peng Lei; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 7.  Protein biomarkers of epileptogenicity after traumatic brain injury.

Authors:  Denes V Agoston; Alaa Kamnaksh
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

Review 8.  Ferroptosis, a Recent Defined Form of Critical Cell Death in Neurological Disorders.

Authors:  Jia-Rui Wu; Qing-Zhang Tuo; Peng Lei
Journal:  J Mol Neurosci       Date:  2018-08-25       Impact factor: 3.444

9.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 10.  The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin.

Authors:  Douglas G Peters; James R Connor; Mark D Meadowcroft
Journal:  Neurobiol Dis       Date:  2015-08-22       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.